ATRA vs MAS · rev $128.9M vs P/E 18, rev $7.83B
Atara Biotherapeutics Inc (ATRA) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
ATRA currently screens at market cap $87.1M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the ATRA and MAS stock pages for the full models.
Not investment advice.